Core Laboratories Inc. $CLB Stock: CWA Asset Management Group LLC Cuts Holdings

Key Points

• CWA Asset Management Group LLC cut its Core Laboratories stake by 90.5% in the third quarter, selling 1.59 million shares and retaining 166,449 shares valued at approximately $1.6 million. Institutional investors and hedge funds collectively own 97.81% of the company.
• Analyst sentiment remains mixed: Johnson Rice upgraded CLB to “buy” with a $21 price target, while Weiss Ratings downgraded it to “sell.” The consensus rating is “hold,” with an average price target of $21.
• Core Laboratories reported quarterly EPS of $0.11, exceeding estimates of $0.09, but revenue fell 4.3% year over year to $124.61 million. Shares opened at $10.12, near the lower end of their 52-week range.

CWA Asset Management Group LLC lessened its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 90.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 166,449 shares of the oil and gas company's stock after selling 1,588,636 shares during the quarter. CWA Asset Management Group LLC owned about 0.36% of Core Laboratories worth $1,615,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Summit Securities Group LLC purchased a new position in Core Laboratories in the first quarter worth approximately $31,000. Isthmus Partners LLC raised its position in Core Laboratories by 16.2% in the first quarter. Isthmus Partners LLC now owns 14,509 shares of the oil and gas company's stock valued at $244,000 after purchasing an additional 2,027 shares during the period. Illinois Municipal Retirement Fund raised its position in Core Laboratories by 12.9% in the first quarter. Illinois Municipal Retirement Fund now owns 25,642 shares of the oil and gas company's stock valued at $431,000 after purchasing an additional 2,930 shares during the period. State of Wyoming raised its position in Core Laboratories by 267.7% in the first quarter. State of Wyoming now owns 4,626 shares of the oil and gas company's stock valued at $78,000 after purchasing an additional 3,368 shares during the period. Finally, Tidal Investments LLC lifted its stake in shares of Core Laboratories by 13.6% in the 2nd quarter. Tidal Investments LLC now owns 80,853 shares of the oil and gas company's stock valued at $942,000 after purchasing an additional 9,652 shares during the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts recently issued reports on CLB shares. Weiss Ratings downgraded Core Laboratories from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Friday, October 2nd. Johnson Rice raised shares of Core Laboratories from a "hold" rating to a "buy" rating and set a $21.00 target price on the stock in a research report on Thursday, August 13th. Finally, Wall Street Zen raised shares of Core Laboratories from a "sell" rating to a "hold" rating in a research report on Saturday, August 1st. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $21.00.

Insider Transactions at Core Laboratories

In other news, CEO Lawrence Bruno bought 5,000 shares of the company's stock in a transaction on Friday, July 31st. The stock was bought at an average cost of $10.78 per share, with a total value of $53,900.00. Following the transaction, the chief executive officer directly owned 262,438 shares in the company, valued at $2,829,081.64. The trade was a 1.94% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.26% of the company's stock.

Core Laboratories Stock Up 0.6%

Shares of NYSE CLB opened at $10.12 on Thursday. The firm has a market cap of $464.54 million, a price-to-earnings ratio of 18.08, a PEG ratio of 2.01 and a beta of 1.14. The company has a quick ratio of 1.55, a current ratio of 2.12 and a debt-to-equity ratio of 0.41. Core Laboratories Inc. has a 52-week low of $9.48 and a 52-week high of $20.36. The business's 50 day moving average is $11.32 and its two-hundred day moving average is $12.56.

Core Laboratories (NYSE:CLB - Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The oil and gas company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.09 by $0.02. Core Laboratories had a return on equity of 10.03% and a net margin of 5.10%. The company had revenue of $124.61 million for the quarter, compared to analysts' expectations of $126.26 million. During the same period in the prior year, the firm earned $0.19 earnings per share. The firm's revenue was down 4.3% compared to the same quarter last year. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Research analysts predict that Core Laboratories Inc. will post 0.56 EPS for the current year.

Core Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Monday, August 10th were paid a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, August 10th. This represents a $0.04 annualized dividend and a yield of 0.4%. Core Laboratories's dividend payout ratio is presently 7.14%.

About Core Laboratories

Core Laboratories N.V. NYSE: CLB is a global provider of proprietary and patented reservoir description and production enhancement services to the energy industry. Its customers include oil and natural gas exploration and production companies, national oil companies, and independent operators.

The company's reservoir description activities include the analysis of rock and fluid samples, core and special core analysis, petrophysical services, geological and reservoir modeling, and laboratory measurements used to evaluate hydrocarbon reservoirs and improve field development decisions.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories Inc. (NYSE:CLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.